REVERSIBLE NEUROTOXICITY DURING INTERLEUKIN-2 THERAPY FOR METASTATIC RENAL-CELL CARCINOMA

被引：3
作者：
VANLAAR, JM
VANBUCHEM, MA
WEYL, N
CLETON, FJ
机构：
[1] UNIV LEIDEN HOSP,DEPT RADIOL,2300 RC LEIDEN,NETHERLANDS
[2] UNIV LEIDEN HOSP,DEPT ONCOL,2300 RC LEIDEN,NETHERLANDS
来源：
EUROPEAN JOURNAL OF CANCER | 1995年 / 31A卷 / 11期
关键词：
D O I：
10.1016/0959-8049(95)00297-V
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1895 / 1897
页数：3
相关论文
共 50 条
[31]   AUTOIMMUNE-THYROIDITIS FOLLOWING INTERLEUKIN-2 AND LAK CELL THERAPY FOR METASTATIC RENAL-CELL CARCINOMA - CORRELATION WITH TUMOR-REGRESSION [J].
BESANA, C ;
SABBADINI, MG ;
CORTI, C ;
DILUCCA, G ;
FOPPOLI, M ;
MARCATTI, M ;
HELTAI, S ;
RUGARLI, C .
TUMORI, 1991, 77 (04) :339-341
[32]   THE ROLE OF INTERFERON AND INTERLEUKIN-2 IN THE IMMUNOTHERAPEUTIC APPROACH TO RENAL-CELL CARCINOMA [J].
FIGLIN, RA ;
ABIAAD, AS ;
BELLDEGRUN, A ;
DEKERNION, JB .
SEMINARS IN ONCOLOGY, 1991, 18 (05) :102-107
[33]   INTERLEUKIN-2 IMMUNOTHERAPY FOLLOWED BY RESECTION OF RESIDUAL RENAL-CELL CARCINOMA [J].
FLEISCHMANN, JD ;
KIM, B .
JOURNAL OF UROLOGY, 1991, 145 (05) :938-941
[34]   INVITRO ACTIVATION OF LYMPHOCYTES BY INTERLEUKIN-2 IN PATIENTS WITH RENAL-CELL CARCINOMA [J].
ZIEGELBAUM, MM ;
FINKE, JH ;
TUBBS, R ;
MONTIE, JE ;
PONTES, JE ;
LEWIS, I .
UROLOGY, 1989, 33 (02) :106-109
[35]   RECOMBINANT INTERLEUKIN-2 IN METASTATIC RENAL-CELL CARCINOMA - A EUROPEAN MULTICENTER PHASE-II STUDY [J].
VONDERMAASE, H ;
GEERTSEN, P ;
THATCHER, N ;
JASMIN, C ;
MERCATELLO, A ;
FOSSA, SD ;
SYMANN, M ;
STOTER, G ;
NAGEL, G ;
ISRAEL, L ;
OSKAM, R ;
PALMER, P ;
FRANKS, CR .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (12) :1583-1589
[36]   CONTINUOUS INTRAVENOUS INTERLEUKIN-2 INFUSION AND SUBCUTANEOUS INTERFERON-ALPHA IN METASTATIC RENAL-CELL CARCINOMA [J].
FOSSA, SD ;
AUNE, H ;
BAGGERUD, E ;
GRANERUD, T ;
HEILO, A ;
THEODORSEN, L .
EUROPEAN JOURNAL OF CANCER, 1993, 29A (09) :1313-1315
[37]   A NEW SCHEDULE OF INTERLEUKIN-2 FOR METASTATIC RENAL-CELL CARCINOMA - THE INSTITUT GUSTAVE-ROUSSY STUDY [J].
ESCUDIER, B ;
FARACE, F ;
THEODORE, C ;
ANGEVIN, E ;
COURT, B ;
COUANET, D ;
DIETRICH, PY ;
CULINE, S ;
PALLARDY, M ;
HERCEND, T ;
DROZ, JP .
BULLETIN DU CANCER, 1995, 82 (04) :296-302
[38]   PEDIATRIC RENAL-CELL CARCINOMA - A COMPLETE RESPONSE TO RECOMBINANT INTERLEUKIN-2 IN A CHILD WITH METASTATIC DISEASE AT DIAGNOSIS [J].
MACARTHUR, CA ;
ISAACS, H ;
MILLER, JH ;
OZKAYNAK, F .
MEDICAL AND PEDIATRIC ONCOLOGY, 1994, 23 (04) :365-371
[39]   INTERLEUKIN-2 WITH OR WITHOUT LAK CELLS IN METASTATIC RENAL-CELL CARCINOMA - A REPORT OF A EUROPEAN MULTICENTER STUDY [J].
NEGRIER, S ;
PHILIP, T ;
STOTER, G ;
FOSSA, SD ;
JANSSEN, S ;
IACONE, A ;
CLETON, FS ;
EREMIN, O ;
ISRAEL, L ;
JASMIN, C ;
RUGARLI, C ;
MASSE, HVD ;
THATCHER, N ;
SYMANN, M ;
BARTSCH, HH ;
BERGMANN, L ;
BIJMAN, JT ;
PALMER, PA ;
FRANKS, CR .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 :S21-S28
[40]   CHEMOIMMUNOTHERAPY OF METASTATIC MURINE RENAL-CELL CARCINOMA USING FLAVONE ACETIC-ACID AND INTERLEUKIN-2 [J].
SALUP, RR ;
SICKER, DC ;
WOLMARK, N ;
HERBERMAN, RB ;
HAKALA, TR .
JOURNAL OF UROLOGY, 1992, 147 (04) :1120-1123
12345